Summary: We describe a retrospective study of long‐term outcome of 46 patients treated and regularly followed in France with 2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1, 3‐cyclohexanedione (NTBC) for tyrosinaemia type I. Most had initial good response with normalization of liver function and metabolic…